Delivery Order SPE2DB24D2011-SPE2DB25FBRXC
- Not listed
- The Defense Logistics Agency awarded a $9,544.90 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity. This contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the vendor based on capability and pricing. The performance location is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded a delivery order valued at $3,047.30 to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Briviact 10 mg/mL oral solution (300 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of June 20, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $4,059.87 to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity. The contract is classified as a firm fixed price delivery order with an ultimate completion date of May 28, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Briviact 10 mg/ml oral solution in a 300 ml quantity. This non-competitive delivery order carries a ceiling value of $5,097.53 and represents a firm fixed price contract with an ultimate completion date of September 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Briviact 10 mg/ml oral solution (300 ml) with a ceiling value of $3,723.56. The contract was competitively awarded without a set-aside designation under a firm fixed-price delivery order structure, with an ultimate completion date of September 22, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a $7,234.61 delivery order to AmerisourceBergen Drug Corp for Briviact 10 mg/ml oral solution (300ml) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price contract represents a competitively awarded, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and running through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Briviact 10 mg/ml oral solution in a 300 ml quantity, with a ceiling value of $1,861.78. This is a firm fixed-price delivery order with no set-aside designation, executed on a competitive basis. The contract is set to reach ultimate completion by June 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity, with a ceiling value of $2,116.72. This competitively awarded, firm fixed-price delivery order is set to be completed by August 13, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,624.15 to AmerisourceBergen Drug Corp for Briviact 75 mg tablets (60-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,138.04 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Briviact 10 mg/mL oral solution in a 300 mL quantity. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery order is issued under...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRXCDelivery Order
The Defense Logistics Agency awarded a $7,351.05 delivery order to AmerisourceBergen Drug Corp for Briviact 10 mg/mL oral solution (300 mL) on September 19, 2025, with completion scheduled for September 22, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply procurement supporting federal medical requirements. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and other government agencies. The parent IDC serves as a global pharmaceutical support vehicle enabling flexible fulfillment of federal medical supply needs across multiple therapeutic domains, with this specific delivery order representing a discrete pharmaceutical requirement within that broader contracting framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 9/19/25 |